ABVC BioPharma, Inc. Operating Lease Liability
ABVC BioPharma, Inc. (ABVC) had Operating Lease Liability of $1.76 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability $1.76M.
- 2026-03-31: Operating Lease, Liability $1.84M.
- 2025-12-31: Operating Lease, Liability $1.92M.
- 2025-09-30: Operating Lease, Liability $369.13K.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $1.76M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $1.84M 10-Q · filed 2026-05-18 |
| 2025-12-31 | $1.92M 10-K · filed 2026-03-03 |
| 2025-09-30 | $369.13K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $459.32K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $533.46K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $640.39K 10-K · filed 2025-04-15 |
| 2024-09-30 | $507.66K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $607.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $708.02K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $809.28K 10-K · filed 2024-03-13 |
| 2023-09-30 | $213.48K 10-Q · filed 2023-11-15 |
| 2023-06-30 | $213.48K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $213.48K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $213.48K 10-Q · filed 2023-11-15 |
| 2022-09-30 | $363.75K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $350.28K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $349.01K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $347.10K 10-Q · filed 2022-11-14 |
| 2020-12-31 | $316.18K 10-K · filed 2022-03-31 |